Breast Cancer

  • Abraxane 2017 report

    Abraxane 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 27 Pages The 5 Key Questions Addressed by this Report:...

  • Afinitor 2017 report

    Afinitor 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 30 Pages The 5 Key Questions Addressed by this Report:...

  • Avastin 2017 report

    Avastin 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 25 Pages The 5 Key Questions Addressed by this Report:...

  • Fareston 2017 report

    Fareston 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Faslodex 2017 report

    Faslodex 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 27 Pages The 5 Key Questions Addressed by this Report:...

  • Halaven 2017 report

    Halaven 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Herceptin 2017 report

    Herceptin 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Ibrance 2017 report

    Ibrance 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Ixempra 2017 report

    Ixempra 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Kadcyla 2017 report

    Kadcyla 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Kisqali 2017 report

    Kisqali 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Perjeta 2017 report

    Perjeta 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 26 Pages The 5 Key Questions Addressed by this Report:...